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EsmololAbstract Background: Beach chair position (BCP) is used in arthroscopic shoulder operations for
its advantages. The BCP together with deliberate hypotension used to decrease intraoperative blood
loss during arthroscopic shoulder procedures, this may have risk to cause postoperative neurolog-
ical insults. Dexmedetomidine and esmolol are used to induce deliberate hypotension. Near-infra-
red spectroscopy (NIRS) provides a non-invasive technique of continuous monitoring of regional
cerebral tissue oxygen saturation (rScO2). In this study we evaluate the prevalence of rScO2 during
hypotensive anesthesia induced by intra-operative infusion of either dexmedetomidine or esmolol in
patients undergoing elective arthroscopic shoulder surgery in the BCP.
Patients and methods: Fifty patients scheduled for elective arthroscopic shoulder surgery under
general anesthesia with hypotensive technique in BCP, randomly assigned into two equal groups,
dexmedetomidine group (D Group) and esmolol group (E Group) according to the drug used
for deliberate hypotension. MAP, HR, BIS and rScO2 were recorded before induction of anesthesia
T0, post-induction of anesthesia T1 as baseline, 5 min after BCP T2, 5 min after starting the studied
drug T3, 30 min T4, 60 min T5, 90 min T6, 5 min after stopping the studied drug T7, 5 min after
return to supine T8 and after extubation T9.
Results: In D group there was signiﬁcant decrease in Lt.rsco2 and Rt.rsco2, at T2 to T7 compared
to T1. In E group there was signiﬁcant decrease in Lt.rsco2 and Rt.rsco2 at T2, to T7 compared to
T1. In D group two patients had CDEs compared to ﬁve patients in E group.
Conclusion: In patients undergoing shoulder arthroscopic surgery under general anesthesia, the
BCP signiﬁcantly decreases rScO2, with further slight decrease of rScO2 with dexmedetomidine
44 K.M. Maghawry et al.and esmolol induced hypotension with no affection of postoperative cognitive function with both
drugs. Dexmedetomidine and esmolol are safe drugs with better safety of dexmedetomidine over
esmolol.
ª 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.1. Introduction
In the last decades open anterior stabilization and capsular
shift were traditionally considered to be ‘‘mainstay and gold
standard’’ for anterior shoulder instability, however, most sur-
geons lately found that arthroscopic anterior stabilization has
become the procedure of choice [1].
The beach chair (BCP) and lateral decubitus (LDP) posi-
tions are both reliable techniques to perform effective arthro-
scopic shoulder operations [2]. The use of BCP for shoulder
arthroscopic procedures started from early 1980s [3]. The
BCP advantages include lack of brachial plexus strain, proper
intra-articular visualization, and ease of conversion to an open
approach if necessary [4], depending on joint positioning and
surgeon training [5].
The BCP in association with deliberate hypotension has
been used to decrease intraoperative blood loss and provide
a relatively blood-free surgical environment to improve surgi-
cal ﬁeld [6]. However, this combination has the potential to
affect cerebral perfusion pressure and oxygenation during sur-
gery and induce cerebral ischemia [7].
Deliberate hypotension can be achieved by using anesthet-
ics, direct acting vasodilators, b adrenergic blockers and cal-
cium channel blockers. However, it may have the risk to
cause postoperative neurological insults due to cerebral hypo-
perfusion [8], so ideal hypotensive agent should be easy admin-
istrated in titration without toxic side effect, have short term
effect, no change in cardiac performance and maintaining cer-
brovascular autoregulation [9].
Dexmedetomidine (DEX) is an imidazole-derivative adre-
noceptor agonist representing high selectivity for a2 adrenergic
agonist [10]. It has a sedative, analgesic and induces inhibition
of central sympathetic outﬂow [11]. It speciﬁcally stimulates
presynaptic a2 receptors [12] with dose dependent decrease in
arterial pressure, heart rate, cardiac output and norepineph-
rine release [13].
Esmolol is a cardio-selective b1 blocker characterized by
ultra-short half life of about 2 min. Its peak effect starts 6–
10 min after IV injection. It is titrated easily with its short
clearance time of average 9 min after stoppage of infusion.
These special pharmacokinetic properties have led to the suc-
cessful use of esmolol in deliberate hypotension [14].
The central nervous system (CNS) is considered to be the
main end-point of most general anesthetics, however, it
remains the least monitored organ during anesthesia [14].
Near-infrared spectroscopy (NIRS) provides a non-invasive
technique of continuous monitoring of regional cerebral tissue
oxygen saturation (rScO2) [15]. This method has been demon-
strated repeatedly to monitor changes in parenchymal and
microcirculatory oxygenation of the frontal cerebral cortex
reﬂecting tissue oxygen use [16] as a marker of the balance
between oxygen supply and demand [17], which allow for
the immediate recognition and management of cerebraldesaturation events (CDEs) that would otherwise be unde-
tected with other conventional intraoperative monitoring dur-
ing procedures with a high risk of adverse neurological
outcomes [18].
The aim of this prospective, randomized, double blind
study was to compare the prevalence of regional cerebral oxy-
gen desaturation during hypotensive anesthesia induced by
intra-operative infusion of either dexmedetomidine or esmolol
in patients undergoing elective arthroscopic shoulder surgery
in the beach chair position with further detection of the occur-
rence of postoperative cognitive dysfunction (POCD).
2. Materials and methods
This prospective, randomized, double blind study was con-
ducted in Prince Salman Hospital in Kingdom of Saudi Arabia
after obtaining the approval of the ethical committee board of
the hospital from February 2013 till December 2013.
A written informed consent was taken from ﬁfty patients
American Society of Anesthesiologists physical status (ASA)
I or II, 20–55 years old scheduled to undergo elective arthro-
scopic shoulder surgery under general anesthesia with hypo-
tensive technique in beach chair position (BCP). Based on a
computer-generated randomization list, patients were classiﬁed
into two groups, dexmedetomidine group (D Group) and
esmolol group (E Group) according to the drug used for delib-
erate hypotension during general anesthesia.
Exclusion criteria included, patients with preexisting cere-
bral pathology (such as previous episodes of cerebral ischemia
or stroke), patients clinically apparent to have neurological or
cognitive dysfunction, cervical stenosis, cervical disk hernia-
tion, documented carotid stenosis, history of serious psychiat-
ric illness, Mini Mental State Examination (MMSE) score of
23 or less and history of orthostatic hypotension, myocardial
infarction or uncontrolled hypertension.
Anesthetic management was carefully standardized in all
patients in both groups. Patients were premedicated with
midazolam IV 0.02 mg/kg after insertion of a 22 G peripheral
intravenous cannula 1 h before induction of anesthesia. Upon
arrival to the operating room, standard monitoring (Aisys;
Datex-Ohmeda, Inc., a General Electric Company, doing busi-
ness as GE Healthcare, Madison, Wisconsin, USA) was
applied; heart rate (HR), non invasive blood pressure, and
oxygen saturation (SPO2) were continuously monitored. Stan-
dard Bispectral Index (BIS) electrode montage (Aspect Med-
ical Systems, Natick, MA) was applied to the forehead before
induction of anesthesia, and BIS was measured continuously
using an Aspect BIS A-2000 monitor version 3.31 (Aspect
Medical Systems).
Patients were actively warmed throughout the procedure
using a forced-air warming system (Bair-Hugger, Augustine-
Medical, Eden Prairie, MN) to maintain intraoperative
normothermia as the esophageal temperature was monitored
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MO) and maintained at 36–37.
Regional cerebral oxygen saturation (rScO2) was continu-
ously monitored using near-infrared spectroscopy (NIRS) with
an INVOS 5100C cerebral oximeter (Somanetics, Troy, MI).
Before induction of general anesthesia, after cleansing the skin
area with alcohol, sensors for cerebral oximeter were placed
bilaterally on the right and left sides of the forehead according
to the manufacturer’s instructions with the caudal border
about 1 cm above the eyebrow with the medial edge at the mid-
line as this position makes the light source and sensors away
from the frontal sinus and temporalis muscle, rScO2 values
from the right and left frontal lobes were averaged to deter-
mine cerebral oxygenation. Another 20 G peripheral cannula
was inserted; one for administration of the study drug and
the other one used for induction of anesthesia.
After full preoxygenation, Granisetron 10 lg/kg IV was
given then anesthesia was induced with propofol (1.5–2.0
mg/kg), and fentanyl (2 lg/kg). The trachea was intubated
2–3 min after administration of cis-atracurium 0.15 mg/kg
IV, and the lungs were mechanically ventilated with 40%
oxygen in nitrous oxide. Anesthesia was maintained by
1–2% end-tidal sevoﬂurane in 40% oxygen in nitrous oxide
ﬂow. Intraoperative ﬂuid administration was 6–8 ml/kg of
lactated ringer solution. Invasive blood pressure monitoring
was done by using a 20 gauge catheter inserted into a radial
artery in the contralateral side of operation and connected to
a pressure transducer (Aisys; Datex-Ohmeda, Inc., a General
Electric Company, doing business as GE Healthcare, Madi-
son, Wisconsin, USA) for continuous monitoring of invasive
blood pressure. The pressure transducer was referenced to
the mid-axillary level when patient was supine and referenced
to the external ear canal level when in BCP to reﬂect directly
cerebral perfusion pressure.
Approximately 10 min after anesthesia induction, when
hemodynamics became stable, the head was secured in neutral
position to ensure that cerebral venous drainage was not
impaired. The back of the operating room table was then
raised to 65–75 above the horizontal plane to put the patient
into the beach-chair position (BCP) using a beach-chair table
(T-MAX beach chair; TENET Medical Engineering, Calgary,
Alberta, Canada), after which the surgery was started.
After induction of anesthesia and the patient positioned in
BCP, D group received loading dose of 1 lg/kg of dexmede-
tomidine {Precedex 200 lg/2 ml (Hospira, USA)} diluted in
10 ml of 0.9% normal saline infused over 10 min then iv
bolus of 10 ml of 0.9% normal saline, followed by infusion
rate 0.2–0.6 lg/kg/h (200 lg dexmedetomidine diluted in
48 ml of 0.9% normal saline injection for a ﬁnal concentra-
tion of 4 lg/ml). Patients who were allocated to E group,
started to receive IV 10 ml of 0.9% normal saline over
10 min followed by iv bolus esmolol 0.5 mg/kg {Brevibloc
100 mg/10 ml (Baxter Deutschland GmbH)} diluted in 10 ml
of 0.9% normal saline followed by infusion rate of
0.05–0.3 mg/kg/min throughout the operation (400 mg
esmolol added to 10 ml of 0.9% normal saline for a ﬁnal
volume 50 ml with concentration of 8 mg/ml).
Patients were mechanically ventilated to maintain the
end-tidal carbon dioxide (ETCO2) tension at 30–35 mmHg.
Neuromuscular blockade was carefully controlled by train-
of-four monitoring, and additional boluses of cis-atracurium
were administered to maintain one twitch response in responseto electrical stimulation of the ulnar nerve during the surgical
procedure.
At the end of main surgical procedures, deliberate hypoten-
sive drug infusion and incremental doses of cisatracurium were
stopped. Paracetamol 1 g IVI over 15 min was given. The
residual of neuromuscular blocker was antagonized with neo-
stigmine 0.05 mg/kg and glycopyrrolate 0.01 mg/kg. After
extubation and full recovery, the patient received 1 mg/kg
pethidine IM as postoperative analgesia then transferred to
the post anesthesia care unit (PACU).
During the maintenance of anesthesia by the hypotensive
technique, tachycardia was deﬁned as a persistent increase in
HR exceeding 90 beats/min for more than 5 min, which was
treated by IV administration of 1 lg/kg of fentanyl. If brady-
cardia occurred (HR < 50 beats/min), it was treated with
0.01 mg/kg of atropine intravenously. MAP was maintained
between 55 and 65 mmHg, hypo tension less than 50 mmHg
of the MAP was treated by a gradual decrease of the studied
drug to achieve the desired MAP, whereas an increase of
MAP of more than 65 mmHg was treated by increasing the
dose of hypotensive drug used.
Routine monitoring included invasive measurement of
mean arterial blood pressure (MAP), heart rate (HR), and
rhythm by 5-lead electrocardiography, pulse oximetry
(O2Sat), BIS, esophageal temperature and regional cerebral
oxygen saturation (rScO2) throughout the surgery. The end-
tidal concentrations of carbon dioxide, sevoﬂurane, and
nitrous oxide were measured using a gas analyzer.
These variables (MAP, heart rate, BIS and rScO2) were
recorded before induction of anesthesia T0 (supine position),
post-induction of anesthesia T1 (supine position) as baseline
values, 5 min after BCP T2, 5 min after starting the studied
drug T3, 30 min after starting the studied drug T4, 60 min after
starting the studied drug T5, 90 min after starting the studied
drug T6, 5 min after stopping the studied drug T7, 5 min after
change from BCP to supine position T8 and after extubation of
the patient T9.
Baseline rScO2 was deﬁned as the average saturation value
over a 1-min period after induction of general anesthesia.
Cerebral desaturation was deﬁned as a reduction of rScO2 less
than 75% of baseline for more than 15 s [19,14], which should
be treated by the attending anesthesiologist by checking the
ventilator, head position, and tubing system, increasing Fio2,
increasing end-tidal CO2 partial pressure if the end-tidal CO2
was less than 30 mmHg, and increasing arterial blood pressure
with intravascular ﬂuid administration and/or vasopressor
drugs as ephedrine (5 mg IV) if MAP pressure was less than
50 mmHg [20].
The number and duration of cerebral desaturation events
(CDEs) together with the number and type of interventions
used to treat CDEs were recorded. In addition, interventions
used to treat MAP reductions which did not decrease rScO2
were also noted. All these data were recorded from BCP until
tracheal extubation.
At postoperative visit on the evening of surgery, the patient
was assessed neurologically by an anesthetist who was not
related to the study, for gross motor and sensory neurologic
evaluation and gross cognitive evaluation (orientation in time
and space, recall of name, date of birth, and address). Any side
effects were recorded.
Cognitive function of the patients was assessed using the
MMSE test the day before surgery and then reassessed 1 wk
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(MMSE) or Folstein test is a brief 30-point questionnaire test
that is used to screen for cognitive impairment. The MMSE
test includes simple questions and problems in a number of
areas: the time and place of the test, repeating lists of words,
arithmetic, language use and comprehension, and basic motor
skills [21] (Table 1).
Postoperative cognitive dysfunction (POCD) was consid-
ered when there was decrease in MMSE score 2 points or more
from preoperative value [20,22].
3. Statistical analysis
Group sample sizes of 25 per group achieved 80% power to
detect a clinically relevant decrease in cerebral oxygen satura-
tion with mean difference of 10 and estimated SD of 5 and
with a signiﬁcance level (alpha) of 0.05 using a two-sided
two-sample t-test.
Statistical analysis was done on a personal computer using
the Statistical Package for Social Sciences version 16.0 (SPSSª
v. 16.0, SPSS Inc., Chicago, IL, USA). Qualitative data were
analyzed with Pearson’s Chi-square test and were presented
as number [%]. Quantitative data were analyzed using
unpaired t-student test for between group comparison, and
paired t-test for within group comparison, data were presented
as mean ± standard deviation. A P value of <0.05 was
considered statistically signiﬁcant.
4. Results
A total of ﬁfty-two adult patients were enrolled in this study,
two cases were excluded throughout the course of the study,
one case excluded due to incomplete data collection and other
one due to unplanned conversion to open surgical procedure.
There was no statistical signiﬁcant difference in the
patients’ demographic data as regards age, sex, weight and
ASA classiﬁcation (Table 2).
There was no statistical signiﬁcant difference between both
groups as regards patient characteristics (see Table 3).
As regards the change in MAP, within group D, there was
signiﬁcant decrease in MAP T2 (71.52 ± 8), T3 (64.5 ± 4), T4
(61.5 ± 2.9), T5 (59.5 ± 2.6), T6 (58.2 ± 2.7) when compared
to T1 (83.5 ± 8.5), and insigniﬁcant decrease in MAP in T7
(77.8 ± 8.4) and T8 (79.6 ± 5.36) compared to T1Table 1 Mini-mental state examination (MMSE).
Category Possible points
Orientation to time 5
Orientation to place 5
Registration 3
Attention and calculation 5
Recall 3
Language 2
Repetition 1
Complex commands 6(83.5 ± 8.5). There was no signiﬁcant change in MAP T9
(80.6 ± 7.3) when compared to T1 (83.5 ± 8.5) (Table 4).
As regards the change in MAP, within group E, there was
signiﬁcant decrease in MAP T2 (69.4 ± 6.7), T3 (64 ± 3.3),
T4 (62.2 ± 5.7), T5 (59.4 ± 3.2), T6 (58.5 ± 3.7) when com-
pared to T1 (83.8 ± 10), and insigniﬁcant decrease in MAP
in T7 (78.2 ± 5.1) and T8 (81.3 ± 9.3) compared to T1
(83.8 ± 10). There was no signiﬁcant change in MAP T9
(82.4 ± 5.9) when compared to T1 (83.8 ± 10) (Table 4).
As regards the change in MAP, in between groups, there
was no signiﬁcant difference between both groups in different
time intervals (Table 4).
As regards the change in HR, within group comparison in
D group, there was signiﬁcant decrease in HR T2 (76.2 ± 8),
T3 (76.9 ± 10), T4 (73.9 ± 6.7), T5 (69.6 ± 6.9), T6
(66.3 ± 7) when compared to T1 (88.4 ± 10.1), and insigniﬁ-
cant decrease in HR in T7 (77.3 ± 8.7), T8 (76.8 ± 9.7) and
T9 (77.6 ± 4) compared to T1 (88.4 ± 10.1) (Table 5).
While, the change in HR, within group comparison in E
group, there was signiﬁcant decrease in HR T2 (74.5 ± 9),
T3 (77.8 ± 10), T4 (71.8 ± 6.2), T5 (67.4 ± 5.6), T6
(67.8 ± 6.4) when compared to T1 (87.3 ± 3.9), and insigniﬁ-
cant decrease in HR in T7 (78.7 ± 7.6) and T8 (81.6 ± 6.4)
compared to T1 (87.3 ± 3.9). There was no signiﬁcant change
in HR T9 (82 ± 7) when compared to T1 (87.3 ± 3.9)
(Table 5).
As regards the change in HR, in between groups, there was
no signiﬁcant difference between both groups in different time
intervals (Table 5).
As regards the BIS readings representing the depth of anes-
thesia, there was no signiﬁcant difference within group com-
parison in both group or in between groups in different time
intervals except if we compared T9 with T1 within group com-
parison in both group as the patient is awake in T9 reading
Fig. 1.
As regards the change in Lt.rsco2 within D group, there was
signiﬁcant decrease in Lt.rsco2 at T2 (76.8 ± 7.8), T3
(71 ± 5.8), T4 (70.4 ± 4.1), T5 (69.6 ± 3.5), T6 (72 ± 5.3)
and T7 (71 ± 5.2) when compared to T1 (88.6 ± 4.3) and
insigniﬁcant decrease in Lt.rsco2 in T8 (86.7 ± 7.7) compared
to T1 (88.6 ± 4.3). There was no signiﬁcant change in Lt.rsco2
at T9 (87.7 ± 4.1) when compared to T1 (88.6 ± 4.3)
(Table 6).
As regards the change in Lt.rsco2 within in E group, there
was signiﬁcant decrease in Lt.rsco2 at T2 (73.5 ± 7.5), T3Description
From broadest to most narrow. Orientation to time has been
correlated with future decline
From broadest to most narrow. This is sometimes narrowed down to
streets and sometimes to ﬂoor
Repeating named prompts
Serial sevens, or spelling ‘‘world’’ backwards It has been suggested
that serial sevens may be more appropriate in a population where
English is not the ﬁrst language
Registration recall
Naming a pencil and a watch
Speaking back a phrase
Varies. Can involve drawing ﬁgure shown
Table 2 Demographic data in both groups.
D group
(Dexmedetomidine)
(n= 25)
E group
(Esmolol)
(n= 25)
P value
Age (yrs) 41.1 ± 10.3 36.9 ± 12 0.2
Sex (M/F) 12/13 14/11 0.6
Weight (kg) 81.6 ± 9.2 83.3 ± 11.4 0.57
ASA I No (%) 11 (44%) 12 (48%) 0.5
ASA II No (%) 14 (56%) 13 (52%)
Data were expressed as mean ± SD or number (%).
Table 4 Changes of mean arterial blood pressure in both D
group (Dexmedetomidine) and E group (Emolol).
D group
(Dexmedetomidine)
(n= 25)
E group
(Esmolol)
(n= 25)
P value
(between groups)
T1 83.5 ± 8.5 83.8 ± 10 0.9
T2 71.52 ± 8* 69.4 ± 6.7* 0.32
T3 64.5 ± 4* 64 ± 3.3* 0.3
T4 61.5 ± 2.9* 62.2 ± 5.7* 0.5
T5 59.5 ± 2.6* 59.4 ± 3.2* 0.9
T6 58.2 ± 2.7* 58.5 ± 3.7* 0.7
T7 77.8 ± 8.4 78.2 ± 5.1 0.8
T8 79.6 ± 5.36 81.3 ± 9.3 0.4
T9 80.6 ± 7.3 82.4 ± 5.9 0.7
Data were expressed as mean ± SD.P value >0.05 was considered
statistically not signiﬁcant.
No statistically signiﬁcant difference between the 2 groups.
* P value <0.001 compared to T1 within the same group.
Table 5 Changes of heart rate in both D group (Dexmede-
tomidine) and E group (Emolol).
D group
(Dexmedetomidine)
(n= 25)
E group
(Esmolol)
(n= 25)
P value
(between groups)
T1 88.4 ± 10.1 87.3 ± 3.9 0.62
T2 76.2 ± 8* 74.5 ± 9* 0.3
T3 76.9 ± 10* 77.8 ± 10* 0.8
T4 73.9 ± 6.7* 71.8 ± 6.2* 0.25
T5 69.6 ± 6.9* 67.4 ± 5.6* 0.22
T6 66.3 ± 7* 67.8 ± 6.4* 0.44
T7 77.3 ± 8.7 78.7 ± 7.6 0.26
T8 76.8 ± 9.7 81.6 ± 6.4 0.37
T9 77.6 ± 4 82 ± 7 0.053
Data were expressed as mean ± SD.P value >0.05 was considered
statistically not signiﬁcant.
No statistically signiﬁcant difference between the 2 groups.
* P value <0.001, compared to T1 within the same group.
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and T7 (68.4 ± 4.8) when compared to T1 (86.9 ± 3.7), and
insigniﬁcant decrease in Lt.rsco2 in T8 (85.5 ± 5.2) compared
to T1 (86.9 ± 3.7). There was no signiﬁcant change in Lt.rsco2
at T9 (85.7 ± 4.4) when compared to T1 (86.9 ± 3.7)
(Table 6).
As regards the change in Lt.rsco2 in between groups, there
was no signiﬁcant difference between both groups in different
time intervals except at T5 there was signiﬁcant decrease in E
group (65.6 ± 5.7) in comparison with D group (69.6 ± 3.5)
at this time Table 6.
As regards the change in Rt.rsco2, within D group, there
was signiﬁcant decrease in Lt.rsco2 at T2 (76 ± 4.6), T3
(70.1 ± 5.6), T4 (71.2 ± 5.4), T5 (70 ± 3), T6 (68.4 ± 3.8)
and T7 (70.9 ± 4) when compared to T1 (87.6 ± 5), and insig-
niﬁcant decrease in Lt.rsco2 in T8 (85 ± 4.3) compared to T1
(87.6 ± 5). There was no signiﬁcant change in Lt.rsco2 at T9
(87.8 ± 4.4) when compared to T1 (87.6 ± 5) (Table 7).
As regards the change in Rt.rsco2, within E group, there
was signiﬁcant decrease in Lt.rsco2 at T2 (74.3 ± 10), T3
(71.9 ± 4.2), T4 (70.6 ± 4.2), T5 (66.3 ± 4.4), T6
(68.7 ± 4.8) and T7 (71.6 ± 3.8) when compared to T1
(87.6 ± 6.8), and insigniﬁcant decrease in Lt.rsco2 in T8
(84.5 ± 4.5) compared to T1 (87.6 ± 6.8). There was no sig-
niﬁcant change in Lt.rsco2 at T9 (88 ± 4.5) when compared
to T1 (87.6 ± 6.8) (Table 7).
As regards the change in Rt.rsco2, in between groups, there
was no signiﬁcant difference between both groups in different
time intervals except at T5 there is signiﬁcant decrease in E
(66.3 ± 4.4) group in comparison with D (70 ± 3) group at
this time (Table 7).Table 3 Patients’ characteristics in both groups.
D group (Dexmedetom
Duration of anesthesia (min) 160.4 ± 11.2
Duration of surgery (min) 143 ± 14.4
Duration of BCP (min) 127 ± 14
Duration of deliberate hypotension (min) 109.7 ± 10.7
MAP T0 (mmHg) 89.3 ± 11.9
Heart rate T0 (beat/min) 84.8 ± 6.3
BIS (T0) 87.6 ± 4.7
Lt.rsco2 (T0)% 83 ± 5.3
Rt.rsco2 (T0)% 82.7 ± 6.6
Data are expressed as mean ± SD.
P-value >0.05 is considered statistically non-signiﬁcant.As regards the occurrence of cerebral desaturation events
(CDEs), only two patients had CDEs in D group compared
to ﬁve patients had CDEs in E group. Each patient in D group
had only one CDEs attack while in E group, three patients hadidine) (n= 25) E group (Esmolol) (n= 25) P value
155.4 ± 14.1 0.2
132 ± 14.2 0.09
116.6 ± 14 0.11
105.8 ± 12 0.15
85.3 ± 8 0.2
80.7 ± 9.2 0.07
87.8 ± 3.5 0.8
81 ± 5 0.3
81 ± 6.2 0.2
Table 6 Changes of Lt.rsco2 in both D group (Dexmedetom-
idine) and E group (Emolol).
D group
(Dexmedetomidine)
(n= 25)
E group
(Esmolol)
(n= 25)
P value
(between groups)
T1 88.6 ± 4.3 86.9 ± 3.7 0.15
T2 76.8 ± 7.8* 73.5 ± 7.5* 0.26
T3 71 ± 5.8* 69.9 ± 6.3* 0.54
T4 70.4 ± 4.1* 71 ± 6.2* 0.79
T5 69.6 ± 3.5* 65.6 ± 5.7* 0.004
T6 72 ± 5.3* 70 ± 5.5* 0.3
T7 71 ± 5.2 * 68.4 ± 4.8* 0.06
T8 86.7 ± 7.7 85.5 ± 5.2 0.5
T9 87.7 ± 4.1 85.7 ± 4.4 0.11
Data were expressed as mean ± SD. P value >0.05 was considered
statistically not signiﬁcant.
* P value <0.05 was considered statistically signiﬁcant compared
to T1.
 Statistically signiﬁcant decrease compared to D group.
Table 7 Changes of Rt.rsco2 in both D group (Dexmedetom-
idine) and E group (Emolol).
D group
(Dexmedetomidine)
(n= 25)
E group
(Esmolol)
(n= 25)
P value
(between groups)
T1 87.6 ± 5 87.6 ± 6.8 0.9
T2 76 ± 4.6* 74.3 ± 10* 0.26
T3 70.1 ± 5.6* 71.9 ± 4.2* 0.2
T4 71.2 ± 5.4* 70.6 ± 4.2* 0.66
T5 70 ± 3* 66.3 ± 4.4*, 0.002
T6 68.4 ± 3.8* 68.7 ± 4.8* 0.28
T7 70.9 ± 4* 71.6 ± 3.8* 0.56
T8 85 ± 4.3 84.5 ± 4.5 0.69
T9 87.8 ± 4.4 88 ± 4.5 0.8
Data were expressed as mean ± SD. P value >0.05 was considered
statistically not signiﬁcant.
* P value <0.05 was considered statistically signiﬁcant compared
to T1.
 Statistically signiﬁcant decrease compared to D group.
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Figure 1 BIS at different time intervals. Columns are mean and
error bars are SD.
48 K.M. Maghawry et al.one CDEs attack and the other two patients each one had two
CDEs attack. Patients in D group who had CDEs attack
require no interventional management and disappeared spon-
taneously, while in E group two patients of the ﬁve who had
CDEs required management by the attending anesthetist to
treat the CDEs attacks as they last more than 30 s (Table 8).
As regards the MMSE score there was no signiﬁcant differ-
ence in both groups within group comparison or in-between
group comparison Fig. 2.
P value >0.05 was considered statistically not signiﬁcant.
5. Discussion
This prospective, randomized, double blind study was con-
ducted to compare the prevalence of rScO2 during hypotensive
anesthesia induced by intra-operative intra-venous infusion of
either dexmedetomidine or esmolol in patients undergoing
elective arthroscopic shoulder surgery in the BCP with further
detection of the occurrence of POCD, as the association of
deliberate hypotension with BCP under general anesthesia
has the potential to induce changes in cerebral perfusion pres-
sure which may be the major etiology of poor neurological
outcomes [23].
Alterations in systemic hemodynamics occur when postural
conditions are changed from supine to BCP, including dimin-
ished cardiac index, stroke volume, and arterial pressure [24]
caused by marked decrease of venous return which persists
for up to 30 min after the positioning in an anesthetized
patient [25]. In conscious subjects, sitting position activates
the sympathetic nervous system, resulting in an increase of sys-
temic blood pressure associated with increased systemic vascu-
lar resistance and sustained reduction in cardiac output.
Compensatory increases in sympathetic nervous system activa-
tion and systemic vascular resistance are attenuated under gen-
eral anesthesia causing more pronounced hypotension [26].
In the current study, MAP decreased abruptly from the
baseline values (T1) when patients were switched to BCP in
both groups, with a statistically signiﬁcant value. MAP was
not statistically signiﬁcant between the 2 groups during the
study. Our ﬁndings corroborate previous studies of Fuchs
and his colleagues [27] and Tange and his colleagues [28]
who have conﬁrmed considerable hemodynamic shift when
positioning from the supine to the BCP.
In D group, this hemodynamic proﬁle after starting the
hypotensive agents can be attributed to the known sympatho-
lytic effect of a2 agonists which are involved in regulating the
autonomic and cardiovascular systems [29]. Dexmedetomidine
sympatholytic action is manifested by dose-dependent decrease
in arterial blood pressure, heart rate, cardiac output and nor-
epinephrine release [30]. This was coinciding with Basar and
his colleagues [31] who investigated the effect of single dose
of dexmedetomidine and reported signiﬁcant reduction in
MAP and HR.
Esmolol is an ultra-short acting selective B1 adrenergic
antagonist and possesses no signiﬁcant membrane stabilizing
activity, given as continuous infusion to induce stable and con-
trollable beta-adrenergic block [32], providing a stable course
of controlled hypotension and produces beneﬁcial effects in
the surgical ﬁeld and in blood conservation [33]. Negative
chronotropic and ionotropic effects of esmolol decrease the
Table 8 Cerebral desaturation events (CDES).
D group (Dexmedetomidine) (n= 25) E group (Esmolol) (n= 25) P value
No. of patient with CDEs 0:1:2 23:2:0 20:3:2 0.7
Management of CDEs (number of patients) 0 2 0.35
0:1:2 = represent number of CDE events.Data are presented as ratio.
P value >0.05 was considered statistically not signiﬁcant.
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Figure 2 MMSE score at different time interval. Columns are
mean and error bars are SD.
Cerebral oxygen saturation monitoring during hypotensive anesthesia in shoulder arthroscopy 49cardiac output which lowers arterial blood pressure. When
heart rate and strength of contractions are decreased this will
reduce arterial pressure and carotid sinus baroreceptors
response [34].
Esmolol had extremely short half-life (about 9 min). This
explained that there was no signiﬁcant change in HR in T9
when compared to T1, in contrast to dexmedetomidine which
had insigniﬁcant decrease in HR in T9 when compared to T1,
as it had more prolonged action compared to esmolol.
In the present study, MAP was maintained between 55 and
65 mmHg as outcome studies have demonstrated that a reduc-
tion of the mean arterial pressure (MAP) to 55–65 mmHg or a
decrease of 30% from baseline is safe with regards to endorgan
perfusion and oxygen delivery [35].
During this research work, invasive blood pressure was
continuously measured at the level of the external auditory
meatus, which is representing the level of the circle of Willis,
to assess accurately cerebral perfusion pressure. This was
explained by the ‘‘open model’’ or ‘‘waterfall’’ theory, as blood
ﬂows vertically from the heart, there is a reduction in arterial
pressure directly related to the weight of the column of blood
[36,37]. This was coinciding with ko and his colleagues [38]
who stated that ‘‘Monitoring cerebral rScO2 and MAP at the
level of brain can be helpful to detect the possibility of cerebral
desaturation earlier’’. However, Pranevicius and his colleagues
[39] stated that no need for modifying the level of measurement
as long as the CVP can be maintained above 18 mmHg.
Factors which may modulate cerebral oximetry values
include depth of anesthesia, anesthetic technique, arterial car-
bon dioxide concentrations, inspired oxygen content and MAP
[40]. Therefore, anesthetic management was carefully stan-
dardized in all patients in both groups, MAP was maintained
between 55 and 65 mmHg, end-tidal carbon dioxide (ETCO2)
tension at 30–35 mmHg and BIS readings representing the
depth of anesthesia, there was no signiﬁcant difference withingroup comparison in both group or in between groups com-
parison in different time intervals reﬂecting stable depth of
anesthesia in both groups all through the anesthesia course.
Brain oxygenation can be measured invasively by jugular
bulb oximetry to measure jugular venous oxygen saturation
(Sjvo2) as an index of cerebral blood ﬂow/metabolism coupling
[15], Sjvo2 is generally accepted as a method for the monitoring
of global cerebral oxygen saturation and rScO2 as a method for
monitoring regional oxygen saturation [19].
NIRS measures the ratio of oxyhemoglobin to total hemo-
globin in a ﬁeld beneath the sensor, and this ratio is expressed
as a percentage of rScO2 on the right and left side [41]. rScO2
has been reported to be more sensitive than jugular venous
oxygen saturation Sjvo2 to brain ischemia. Also, McLeod
and his colleagues found that NIRS correlated more closely
with changes in Sjvo2 [42]. So, rScO2 may be an alternative
method for detecting brain ischemia during induced hypoten-
sion [43].
In the present study, there was signiﬁcant decrease in both
Rt.rsco2 and Lt.rsco2 with BCP after induction of general anes-
thesia in both groups, however Fuchs and his colleagues [27]
found that rScO2 values in the BCP were not different from
those in the supine position in non-anesthetized volunteers.
However, rScO2 values in the sitting position were signiﬁcantly
lower than those in the supine position in anesthetized
patients, although their MAP was maintained. These results
were explained by the role of general anesthesia in impairment
of regulatory pathways of peripheral circulation and cerebral
autoregulation and thus indicate that changes in rScO2 related
to BCP cannot be only explained by changes in hemodynamic
parameters as MAP.
In our study Rt.rsco2 and Lt.rsco2 values were inﬂuenced
also by deliberate hypotension in both groups. Our results
were agreed with Lee and his colleagues [44] who found that
the BCP combined with induced hypotension signiﬁcantly
decreases rSO2 in patients undergoing shoulder arthroscopic
surgery under general anesthesia; however they used remifen-
tanil and nitroglycerine in deliberate hypotension. Also,
Endoh and his colleagues [45] who found decreased rsco2 in
controlled hypotension induced by nicardipine. But in our
work it was found that there was signiﬁcant decrease in Rt.rsc-
o2 and Lt.rsco2 in E group compared with D group at T5, but
this was in contrast to the results of Heinke and his colleagues
[46] who stated that moderate esmolol doses do not change
cognitive performance and had no direct effects on CBF, so
this excludes regional or global effects of esmolol on CBF.
However, this study did not use higher esmolol doses which
may cause a greater reduction of cardiovascular variables.
Moreover, this study was done in awake volunteers, so
whether these data can be applied under general anesthesia
with BCP, needs to be clariﬁed in future investigations.
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undergoing elective shoulder surgery in the beach chair posi-
tion in many previous studies is quite variable and ranges from
8% to 80% [47,48,44,49,28]. Despite the frequent occurrence
of CDEs in these patients, no clear neurologic insults were doc-
umented [48]. This can be explained by limited duration of the
surgical procedure, as severity and duration of cerebral hypo-
perfusion are critical determinants of tissue damage, so, viabil-
ity-time thresholds usually not exceeded to cause neurologic
deﬁcits [50].
The normal range for rScO2 values was variable in different
studies, Madsen and his colleagues [51] stated that the normal
range for rScO2 values in 39 healthy resting subjects is 55–78,
Similarly, Casati and his colleagues [14] reported baseline rSc-
O2 values 63 ± 8 in healthy elderly patients undergoing gen-
eral surgery, also Kim and his colleagues [52] reported that
mean baseline rScO2 value was 71 ± 6 in healthy volunteers
aged 20–36 years.
In the present study we deﬁned cerebral desaturation events
(CDEs), as a reduction of rScO2 less than 75% of baseline for
more than 15 s in agreement with Casati and his colleagues [22]
and Iglesias and his colleagues [53], however other literature
deﬁned a CDE as a drop in rScO2 of 20% or greater from base-
line or an rScO2 of less than 55% for any time period [18] and
this deﬁnition depend on the fact that in conscious patients, a
20% decrease in frontal lobe oxygenation is associated with
clinical symptoms and signs of cerebral ischemia [54]. Also
during carotid endarterectomy, 20% or greater drop in rScO2
during clamping of carotid artery is associated with a 20-fold
increase in obvious signs and symptoms of cerebral ischemia
[55].
In the present study, the MMSE was used for evaluating
cognitive function as it has many advantages include high
validity and reliability, ease of use, brevity and suitability for
bedside use. Also, MMSE is very appropriate for repeated cog-
nitive assessments over time [22]. There are other sensitive and
speciﬁc scores as regards the assessment of cognitive functions
evaluating different components of cognitive function; how-
ever, they have major drawback of lengthy, complex adminis-
tration guidelines and long time in its application [56].
In our study, as regards the MMSE score there was no sig-
niﬁcant difference in both groups within group comparison or
in-between group comparison. This was coinciding with Wil-
liams-Russo and his colleagues [57] who found no POCD after
hypotensive epidural anesthesia in elderly patients. Also, Tow-
nes and his colleagues [58] reported there were no neuropsy-
chological changes or decrease in MMSE score after induced
hypotension in healthy young adults.
The absence of a signiﬁcant difference between preoperative
and postoperative MMSE values could be explained by proper
management of any intra-operative CDEs. Also, proper mon-
itoring of rScO2 values after BCP and induced hypotension
preserve intra-operative cerebral perfusion and oxygenation
which may protect the CNS from any insult.
6. Conclusion
In patients undergoing shoulder arthroscopic surgery under
general anesthesia, the beach-chair position signiﬁcantly
decreases rScO2, with further slight decrease of rScO2 with dex-
medetomidine and esmolol induced hypotension with no affec-
tion of postoperative cognitive function with both drugs.Dexmedetomidine and esmolol are safe drugs for induced
hypotension as rScO2 values are well maintained during hypo-
tension with better safety of dexmedetomidine over esmolol
which had more incidences of intraoperative CDEs.Conﬂict of interest
None.
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